Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.

Chaber R, Fiszer-Maliszewska L, Noworolska-Sauren D, Kwasnicka J, Wrobel G, Chybicka A.

J Pediatr Hematol Oncol. 2013 Apr;35(3):180-7. doi: 10.1097/MPH.0b013e318286d29b.

PMID:
23511489
2.

Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.

Coustan-Smith E, Kitanaka A, Pui CH, McNinch L, Evans WE, Raimondi SC, Behm FG, Aricò M, Campana D.

Blood. 1996 Feb 1;87(3):1140-6.

3.

[Expression of CREB/Bcl-2 in bone marrow mononuclear cells of children with acute leukemia].

Wen C, Ma FT, Wan WQ.

Zhongguo Dang Dai Er Ke Za Zhi. 2010 Mar;12(3):177-80. Chinese.

4.

Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.

Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.

J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. Review.

PMID:
11902303
5.
6.

5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype.

Castro FV, McGinn OJ, Krishnan S, Marinov G, Li J, Rutkowski AJ, Elkord E, Burt DJ, Holland M, Vaghjiani R, Gallego A, Saha V, Stern PL.

Leukemia. 2012 Jul;26(7):1487-98. doi: 10.1038/leu.2012.18.

7.

[Expression of MOST-1 mRNA in bone marrow mononuclear cells from patients with acute lymphoblastic leukemia].

Gao J, Yuan LX, Sun L, Li XX, Liao QK.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Sep;35(5):638-40. Chinese.

PMID:
15460406
8.

Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group.

Tsurusawa M, Saeki K, Katano N, Fujimoto T.

Pediatr Hematol Oncol. 1998 Mar-Apr;15(2):143-55.

PMID:
9592841
9.

Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.

Morishita N, Tsukahara H, Chayama K, Ishida T, Washio K, Miyamura T, Yamashita N, Oda M, Morishima T.

Pediatr Blood Cancer. 2012 Jul 15;59(1):83-9. doi: 10.1002/pbc.24034.

PMID:
22183914
10.

Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.

Uckun FM, Yang Z, Sather H, Steinherz P, Nachman J, Bostrom B, Crotty L, Sarquis M, Ek O, Zeren T, Tubergen D, Reaman G, Gaynon P.

Blood. 1997 May 15;89(10):3769-77.

11.

The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia.

de Bock CE, Ardjmand A, Molloy TJ, Bone SM, Johnstone D, Campbell DM, Shipman KL, Yeadon TM, Holst J, Spanevello MD, Nelmes G, Catchpoole DR, Lincz LF, Boyd AW, Burns GF, Thorne RF.

Leukemia. 2012 May;26(5):918-26. doi: 10.1038/leu.2011.319.

PMID:
22116550
12.

Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.

Troeger A, Siepermann M, Escherich G, Meisel R, Willers R, Gudowius S, Moritz T, Laws HJ, Hanenberg H, Goebel U, Janka-Schaub GE, Mahotka C, Dilloo D.

Haematologica. 2007 Aug;92(8):1043-50.

13.

Effect of Bcl-2-siRNA on proliferation and apoptosis of pediatric acute B lymphoblastic leukemia (A-BLL) cells.

Meng WB, Liu JP, Wang XW, E LH.

Genet Mol Res. 2015 Oct 16;14(4):12427-36. doi: 10.4238/2015.October.16.9.

14.

Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism.

Inoue H, Takemura H, Kawai Y, Yoshida A, Ueda T, Miyashita T.

Jpn J Cancer Res. 2002 May;93(5):582-90.

PMID:
12036455
15.

CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemia.

Rhein P, Mitlohner R, Basso G, Gaipa G, Dworzak MN, Kirschner-Schwabe R, Hagemeier C, Stanulla M, Schrappe M, Ludwig WD, Karawajew L, Ratei R.

Blood. 2010 May 6;115(18):3763-71. doi: 10.1182/blood-2009-10-247585.

17.

IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.

Sasson SC, Smith S, Seddiki N, Zaunders JJ, Bryant A, Koelsch KK, Weatherall C, Munier ML, McGinley C, Yeung J, Mulligan SP, Moore J, Cooper DA, Milliken S, Kelleher AD.

Cytokine. 2010 Apr;50(1):58-68. doi: 10.1016/j.cyto.2009.12.001.

PMID:
20060740
18.

[Expression of transferrin receptor 2 in mononuclear cells from children with acute leukemia].

Pan LL, Gao J, Chen TT, Ma ZG, Guo X, Zhu YP, Li Q, Yuan LX.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 Jan;40(1):20-3, 76. Chinese.

PMID:
19292036
19.

Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.

Te Kronnie G, Bicciato S, Franceschini L, Accordi B, DellĂ­orto MC, Rinaldi A, Pession A, Barisone E, Conter V, Locatelli F, Basso G.

Oncol Rep. 2006 Feb;15(2):341-6.

PMID:
16391852
20.

[Expression of zinc finger protein X-linked in childhood B lineage acute lymphoblastic leukemia].

Wang Z, Liang HH, Li BS, Huang XH, Zhang J, Wang X, Ding LX, Jiang H.

Zhongguo Dang Dai Er Ke Za Zhi. 2013 Jul;15(7):509-13. Chinese.

Items per page

Supplemental Content

Support Center